Silver-Russell syndrome due to 7p11.2p13 microduplication

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:231137Q87.1
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Silver-Russell syndrome due to 7p11.2p13 microduplication is a rare genetic condition that represents one of the molecular subtypes of Silver-Russell syndrome (SRS). This form is caused by a microduplication in the short arm of chromosome 7, specifically in the 7p11.2 to 7p13 region. Silver-Russell syndrome is a clinically heterogeneous imprinting disorder primarily characterized by severe intrauterine and postnatal growth restriction, resulting in short stature that is disproportionate with relative macrocephaly (a head that appears large relative to the body). Affected individuals typically present with a triangular facial appearance, prominent forehead, body asymmetry (limb length discrepancy), feeding difficulties in early life, and low body mass index. Clinodactyly of the fifth finger is also commonly observed. The condition affects multiple body systems, including the musculoskeletal system (growth restriction, asymmetry), the craniofacial region (characteristic facial features), and the gastrointestinal system (feeding difficulties and failure to thrive in infancy). Some patients may also experience developmental delay or learning difficulties, though cognitive outcomes are variable. Growth restriction is typically evident prenatally, with low birth weight and length for gestational age being hallmark features. There is no cure for Silver-Russell syndrome due to 7p11.2p13 microduplication, but management is multidisciplinary and supportive. Growth hormone therapy is a well-established treatment that can improve final adult height and body composition. Nutritional support is critical in early childhood to address feeding difficulties and promote adequate caloric intake. Orthopedic monitoring may be needed for limb length discrepancy, and developmental support services can help address any learning or speech delays. Regular follow-up with endocrinology, genetics, and other specialists is recommended throughout childhood and into adulthood.

Also known as:

Clinical phenotype terms— hover any for plain English:

Labial hypoplasiaHP:0000066Narrow noseHP:0000460
Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Silver-Russell syndrome due to 7p11.2p13 microduplication.

View clinical trials →

No actively recruiting trials found for Silver-Russell syndrome due to 7p11.2p13 microduplication at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Silver-Russell syndrome due to 7p11.2p13 microduplication community →

No specialists are currently listed for Silver-Russell syndrome due to 7p11.2p13 microduplication.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Silver-Russell syndrome due to 7p11.2p13 microduplication.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Silver-Russell syndrome due to 7p11.2p13 microduplicationForum →

No community posts yet. Be the first to share your experience with Silver-Russell syndrome due to 7p11.2p13 microduplication.

Start the conversation →

Latest news about Silver-Russell syndrome due to 7p11.2p13 microduplication

No recent news articles for Silver-Russell syndrome due to 7p11.2p13 microduplication.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Silver-Russell syndrome due to 7p11.2p13 microduplication

What is Silver-Russell syndrome due to 7p11.2p13 microduplication?

Silver-Russell syndrome due to 7p11.2p13 microduplication is a rare genetic condition that represents one of the molecular subtypes of Silver-Russell syndrome (SRS). This form is caused by a microduplication in the short arm of chromosome 7, specifically in the 7p11.2 to 7p13 region. Silver-Russell syndrome is a clinically heterogeneous imprinting disorder primarily characterized by severe intrauterine and postnatal growth restriction, resulting in short stature that is disproportionate with relative macrocephaly (a head that appears large relative to the body). Affected individuals typically

At what age does Silver-Russell syndrome due to 7p11.2p13 microduplication typically begin?

Typical onset of Silver-Russell syndrome due to 7p11.2p13 microduplication is neonatal. Age of onset can vary across affected individuals.